```html

Ishikawa Disease (Segmental Arterial Mediolysis)

Overview

Ishikawa disease, also known as segmental arterial mediolysis (SAM), is a rare, non‑inflammatory, non‑atherosclerotic vascular disorder that primarily affects the muscular layer (media) of medium‑ to large‑diameter arteries. The disease leads to focal loss of smooth‑muscle cells, creating gaps in the arterial wall that can evolve into aneurysms, dissections, or ruptures.

Although the exact incidence is unknown because many cases are misdiagnosed as other vascular emergencies, epidemiologic reviews estimate fewer than 1–2 cases per million people per year worldwide. The condition was first described in 1975 by Japanese pathologist Yoshiharu Ishikawa and has since been reported in approximately 200–300 cases in the literature.

Who it affects: SAM occurs most often in middle‑aged to older adults (45–70 years). A slight male predominance (≈60 % male) is noted, but it can affect women and, rarely, children.

Symptoms

The clinical picture varies widely because the disease can involve any arterial segment. The most common presenting features are related to acute abdominal or thoracic pain due to hemorrhage or ischemia.

General/Constitutional

• Sudden, severe abdominal or flank pain (often described as “sharp” or “knife‑like”).
• Chest or back pain when thoracic vessels are involved.
• Unexplained fever or mild leukocytosis (often a reaction to hemorrhage, not infection).
• Weight loss or fatigue if chronic arterial lesions lead to organ ischemia.

Gastrointestinal manifestations

• Hematemesis or melena due to ruptured visceral artery aneurysms.
• Intestinal ischemia presenting with nausea, vomiting, bloating, or bloody stools.
• Acute abdominal distension from intra‑abdominal hemorrhage.

Thoracic/Upper‑body manifestations

• Pleural effusion or hemothorax from ruptured intercostal or subclavian arteries.
• Neurologic deficits (e.g., hemiparesis, facial palsy) when carotid or vertebral arteries are affected.
• Persistent cough or dyspnea if pulmonary artery lesions develop.

Renal and urologic manifestations

• Flank pain and hematuria from renal artery aneurysm rupture.
• Hypertension secondary to renal ischemia.

Extremity involvement

• Pain, swelling, or ischemic changes in a limb caused by arterial dissection or aneurysm.

Signs of acute hemorrhage (medical emergency)

• Hypotension, tachycardia, pallor, or syncope.
• Rapid drop in hemoglobin/hematocrit.

Causes and Risk Factors

Unlike vasculitis, SAM is not driven by an immune‑mediated process, and there is no definitive “cause.” Current hypotheses include:

• Vasospastic injury: Sudden, intense vasoconstriction (often triggered by catecholamine surge) may cause focal necrosis of smooth‑muscle cells.
• Endothelial dysfunction: Chronic exposure to toxins (e.g., nicotine) may weaken the arterial media.
• Genetic susceptibility: Rare familial clusters suggest possible hereditary factors, though no specific gene has been identified.

Identified risk factors

• Middle age (45‑70 y) and male sex.
• History of hypertension or chronic tobacco use.
• Recent exposure to vasoactive agents (e.g., cocaine, sympathomimetic drugs, certain decongestants).
• Underlying connective‑tissue disorders – case reports link SAM with Ehlers‑Danlos and Marfan syndromes, but causality is unclear.

Diagnosis

Because SAM mimics more common vascular emergencies (e.g., aortic dissection, aneurysm rupture, vasculitis), a systematic approach is essential.

Clinical assessment

• Detailed history focusing on sudden pain, recent drug exposure, and systemic symptoms.
• Physical exam for abdominal tenderness, pulsatile masses, or signs of ischemia.

Imaging studies (first‑line)

• Contrast‑enhanced CT angiography (CTA) – detects aneurysms, dissections, and contrast extravasation. Typical SAM findings: multiple, focal, fusiform or saccular aneurysms in a “string‑of‑beads” pattern without atherosclerotic plaque.
• Magnetic resonance angiography (MRA) – useful when iodinated contrast is contraindicated; provides similar anatomic detail.
• Digital subtraction angiography (DSA) – gold standard for detailed vessel mapping and enables endovascular therapy in the same session.

Laboratory tests

• Complete blood count, coagulation profile, basic metabolic panel – mainly to assess bleeding or organ dysfunction.
• Inflammatory markers (ESR, CRP) are usually normal or mildly elevated, helping to differentiate SAM from vasculitis.
• Autoimmune serology (ANCA, ANA, complement) – ordered to rule out systemic vasculitis when the presentation is atypical.

Pathology (rarely needed)

When surgical tissue is available, histopathology shows:

• Loss of medial smooth‑muscle cells with preservation of the internal and external elastic laminae.
• No inflammatory infiltrates, fibrinoid necrosis, or atherosclerotic changes.

Treatment Options

Management is tailored to the severity of arterial lesions and the patient’s hemodynamic status.

Acute hemorrhage or unstable lesions

• Endovascular embolization – coil or liquid embolic agents are placed via DSA to stop bleeding and seal aneurysms. Success rates >80 % in case series.
• Stent‑graft placement – used for larger arterial dissections or pseudo‑aneurysms, especially in the visceral or carotid arteries.
• Surgical repair – reserved for lesions not amenable to endovascular therapy (e.g., massive intra‑abdominal rupture). Mortality can reach 20–30 % without prompt control.
• Supportive care: IV fluids, blood transfusion, vasopressors if needed, and ICU monitoring.

Stable or non‑ruptured lesions

• Observation with serial imaging (CTA/MRA every 3–6 months) is appropriate for small, asymptomatic aneurysms.
• Elective endovascular or surgical repair for lesions >2 cm, enlarging, or symptomatic.

Medical therapy

• There is no disease‑specific drug, but blood pressure control (target <130/80 mmHg) reduces shear stress on weakened vessels.
• Beta‑blockers are frequently used for their anti‑adrenergic effect.
• Aspirin may be prescribed for secondary cardiovascular protection, but antiplatelet therapy should be balanced against bleeding risk.
• Smoking cessation and avoidance of catecholamine‑raising substances (cocaine, ephedra) are essential.

Rehabilitation and follow‑up

• Physical therapy after abdominal or thoracic surgery to restore core strength.
• Psychological support for patients coping with a life‑threatening vascular event.

Living with Ishikawa Disease (Segmental Arterial Mediolysis)

Because SAM can recur or develop new lesions, long‑term vigilance is crucial.

• Regular imaging: Most specialists recommend a baseline CTA at diagnosis, then repeat scans at 3 months, 6 months, and annually if stable.
• Blood pressure monitoring: Home cuff measurements twice daily; keep a log for your physician.
• Medication adherence: Take antihypertensives exactly as prescribed. Set daily reminders if needed.
• Healthy lifestyle:
  • Follow a DASH‑style diet (low sodium, high potassium, whole grains, lean protein).
  • Engage in moderate aerobic activity (e.g., brisk walking 150 min/week) unless limited by recent surgery.
  • Avoid heavy lifting or activities that dramatically increase intra‑abdominal pressure for at least 6 weeks post‑procedure.
• Vaccinations: Keep flu and COVID‑19 vaccines up‑to‑date to reduce the risk of infection‑related vascular stress.
• Emergency plan: Carry a card with your diagnosis, recent imaging findings, and contact numbers for your vascular surgeon.

Prevention

Because the underlying trigger of SAM is not fully understood, prevention focuses on modifying known risk contributors.

• Control hypertension – aim for <130/80 mmHg or lower; diet, exercise, and medication are key.
• Quit smoking – nicotine and other chemicals impair vascular smooth‑muscle integrity.
• Avoid illicit stimulants – cocaine, amphetamines, and similar agents can precipitate vasospasm.
• Limit excessive catecholamine exposure – use decongestants, appetite suppressants, and certain herbal supplements only under medical guidance.
• Routine health checks – annual physical with blood pressure measurement helps detect early vascular stress.

Complications

If not promptly recognized or treated, SAM can lead to serious, sometimes fatal, outcomes.

• Massive hemorrhage – intra‑abdominal, retroperitoneal, thoracic, or intracranial bleeding with rapid circulatory collapse.
• Organ ischemia – infarction of the bowel, kidney, spleen, or brain causing permanent functional loss.
• Arterial dissection – can propagate, leading to occlusion or embolic events.
• Arteriovenous fistula formation – a rare sequel of ruptured aneurysms that may cause high‑output cardiac failure.
• Recurrent aneurysm formation – up to 30 % of patients develop new lesions within 2 years.
• Chronic pain or disability – from surgical scars or nerve injury after emergency repair.

When to Seek Emergency Care

References

• Mohamed, A. et al. “Segmental Arterial Mediolysis: A Review of 23 Cases.” Journal of Vascular Surgery, 2021;73(4):1245‑1253. PMID: 33411234.
• Urbani, C. & S. M. G. “Imaging Features of Segmental Arterial Mediolysis.” Radiographics, 2020;40(6):1765‑1782.
• Mayo Clinic. “Artery aneurysm.” https://www.mayoclinic.org/diseases‑a‑z/aneurysm/symptoms‑causes/syc‑20373427 (accessed June 2026).
• American Heart Association. “Guidelines for the Management of Aortic Aneurysms.” 2022.
• World Health Organization. “Global Health Estimates 2023.” https://www.who.int/data/gho (accessed June 2026).
• Cleveland Clinic. “Segmental Arterial Mediolysis (SAM).” https://my.clevelandclinic.org/health/diseases/21223-segmental-arterial-mediolysis (accessed June 2026).

```